论文部分内容阅读
卡介苗活性疫苗 (BCG)膀胱灌注在治疗膀胱浅表移行上皮癌和预防膀胱癌术后复发的作用在临床上已得到肯定[1] 。因其在购买 ,贮存上不方便 ,药价昂贵难以推广 ,且在BCG膀胱灌注后 ,可导致较重的局部和全身反应 ,如严重的膀胱刺激症状、高热等 ,患者常因此中止治疗[2 ] 。
The role of BCG bladder irrigation in the treatment of superficial bladder transitional epithelial cancer and prevention of postoperative recurrence of bladder cancer has been clinically confirmed [1]. Because of its inconvenience in purchase and storage, expensive drugs are difficult to popularize, and patients often discontinue treatment after BCG bladder perfusion, which can lead to severe local and systemic reactions such as severe bladder irritation and fever. ].